24 Oct CLSI has provided testing and interpretive criteria for common organisms. • Labs occasionally need to test “infrequently isolated or fastidious”. 15 Aug Home; CLSI M45 Clinical and Laboratory Standards Institute document M Methods for Antimicrobial Dilution and Disk CLSI MA2. D(ABMM) Thomas R. CLSI document MA2 (ISBN ).clsi. contact us at: Telephone: West Valley Road. in vitro antimicrobial.

Author: Tokora Maulkis
Country: Angola
Language: English (Spanish)
Genre: Science
Published (Last): 16 July 2015
Pages: 44
PDF File Size: 4.96 Mb
ePub File Size: 18.17 Mb
ISBN: 765-6-24401-685-4
Downloads: 97625
Price: Free* [*Free Regsitration Required]
Uploader: Zulumuro

Close mobile search navigation Article navigation. It furthers clsi m45-a2 University’s objective of excellence in research, scholarship, and education by publishing worldwide.

It also includes a series of procedures designed to standardize test performance. Jorgensen, PhD, chairholder of the CLSI working group clsi m45-a2 developed the document, it has long been accepted that for the most effective management of bacterial infections, laboratories must clsi m45-a2 able to determine susceptibility or resistance to therapeutic agents.

Not Logged In Member?: The performance, applications, clsi m45-a2 limitations of the current CLSI-recommended methods are described. Jorgensen theorizes that diagnostic device companies may even modify their products to gain regulatory eg, FDA clearance for marketing to clinical laboratories. Oxford University Press is a department of the University of Oxford. View all product details.

Susceptibility testing is especially necessary if the etiological agent is resistant, or possibly resistant, to a commonly used antimicrobial agent.

They were placed clsi m45-a2 your computer when you launched this website. Our policy towards the use of cookies Techstreet, a Clarivate Analytics brand, uses cookies to improve your online experience. M45 addresses the modifications required to test these organisms and provides expert guidance on how to interpret results, including identifying the essential breakpoints.

Full Description If a bacterial pathogen’s susceptibility to antimicrobial agents cannot be predicted based on clsi m45-a2 identity of the organism alone, in vitro antimicrobial susceptibility testing of the isolated organism may be indicated.

Jorgensen and Hindler both agree that this revised guideline is very timely, in light of the increasingly common challenges faced by laboratories performing susceptibility clsi m45-a2 on these organisms, including increased pressure from clinicians to provide susceptibility data quickly, and the need for reliable methods to identify emerging resistance.


His e-mail address is glenmcdan aol. In such cases, in vitro antimicrobial susceptibility of the organism isolated is most likely indicated. However, in cases such as those involving fastidious and infrequently isolated organisms for which specific guidelines do not exist, laboratorians have resorted to various alternative methods and applied breakpoints from other groups of organisms.

However, there are instances in which the sensitivity of such a pathogen cannot be predicted simply based on the identity of the clsi m45-a2. These methods may also be used to evaluate commercial clsi m45-a2 for routine use. Before the publication of this guideline, a review of the literature revealed very few systematic studies on testing these organisms, Dr. These organisms include Helicobacter pyloriVibrio choleraeand potential agents of bioterrorism, adds Hindler.

Commercial susceptibility testing devices are not specifically addressed by M Jorgensen identifies these developments as the most obvious benefits of M While comprehensive, the guideline is not prescriptive, and allows some degree of customization of criteria and policies by each laboratory and its medical staff.

Clsi m45-a2 guideline is based somewhat on standardized procedures in other documents, but contains specific instructions on when clsi m45-a2 how to perform antimicrobial susceptibility testing of fastidious or infrequently isolated organisms that clsi m45-a2 be resistant to clsi m45-a2 commonly prescribed through antibiotics.

You can change your cookie settings through your browser.

Popular Publishers

Sign In clsi m45-a2 Create an Account. Susceptibility testing is particularly necessary in those situations in which the etiological agent belongs to a bacterial species for which resistance to commonly used antimicrobial agents has been documented, or could arise. M45 does not suggest that clsi m45-a2 test all infrequently encountered or fastidious isolates, especially if they are of dubious clsi m45-a2 significance, Dr.

Related articles in Google Scholar. A variety of laboratory techniques can be used to measure the in vitro susceptibility of bacteria to antimicrobial agents. Prompt, accurate identification of a bacterial pathogen is one of the most valuable services the microbiology laboratory provides for clinicians in its efforts to positively impact patient clsi m45-a2.


The Experts James H. Therefore, laboratories need specific guidelines on how to perform valid susceptibility testing without using the US Food and Drug Administration FDA -cleared clsi m45-a2 and commercial test systems found in most laboratories. For some of the organisms, a disk diffusion method is described, and this method can be easily adopted by most clinical laboratories performing disk diffusion testing.

CLSI is a global, nonprofit organization that promotes the development and use of voluntary consensus standards and guidelines within the health care community. Citing articles via Google Scholar. Receive exclusive offers and clsi m45-a2 from Oxford Academic. Jorgenson stresses the importance of understanding their distinction from M Clsi m45-a2, clinicians need prompt guidance on treating organisms that can cause serious, life-threatening infections eg, bacteremia, endocarditis, and meningitis.

Established guidelines exist for susceptibility testing of some organisms.

— Page Not Found

Its encompassing nature establishes M45 as an invaluable resource to various constituencies, including the clinical laboratory. The methods described are generic reference methods that can clzi used for routine susceptibility testing by most clinical laboratories. Results generated by these reference methods may in fact m455-a2 used by regulatory agencies to evaluate the performance of commercial systems clsi m45-a2 part of their approval systems.

According to James H. Interested facilities should contact CLSI for more information, including clsi m45-a2 options, on this essential clsi m45-a2. Jorgensen offers an example of how this guideline might be used in a typical laboratory.

Working group member Paul C. Email clsi m45-a2 New issue alert.